CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Operating Officer bought 8,680 shares at $2.88 ($24,998)
- 4 Open-market buy Chief Executive Officer bought 8,680 shares at $2.88 ($24,998)
- 4 Open-market sale Director sold 198 shares at $3.70 ($732)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.99 ($49,900)
- 4 Open-market buy Chief Operating Officer bought 10,000 shares at $4.99 ($49,900)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $4.99 ($24,950)
- 4 Open-market buy Chief Operating Officer bought 30,000 shares at $0.28 ($8,400)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 11 · 211 filings